Escitalopram and paroxetine in the treatment of generalised anxiety disorder: randomised, placebo-controlled, double-blind study.

@article{Baldwin2006EscitalopramAP,
  title={Escitalopram and paroxetine in the treatment of generalised anxiety disorder: randomised, placebo-controlled, double-blind study.},
  author={David S. Baldwin and Anna Karina Trap Huusom and Eli Maehlum},
  journal={The British journal of psychiatry : the journal of mental science},
  year={2006},
  volume={189},
  pages={
          264-72
        }
}
BACKGROUND It is uncertain whether higher doses of selective serotonin reuptake inhibitors have greater efficacy in generalised anxiety disorder. AIMS To assess the efficacy of different doses of escitalopram in generalised anxiety disorder. METHOD Randomised, double-blind, placebo-controlled, fixed-dose, parallel-group, 12-week study, with 681 patients: placebo (n=139); escitalopram, 5 mg/day, (n=134); 10 mg/day (n=136); 20 mg/day (n=133); paroxetine, 20 mg/day (n=139). RESULTS Mean… CONTINUE READING
Recent Discussions
This paper has been referenced on Twitter 1 time over the past 90 days. VIEW TWEETS
29 Citations
11 References
Similar Papers

Citations

Publications citing this paper.
Showing 1-10 of 29 extracted citations

References

Publications referenced by this paper.
Showing 1-10 of 11 references

A double - blind comparison of escitalopram and paroxetine in the long - term treatment of generalized anxiety disorder

  • O. Brawman-Mintzer, R. G. Knapp, M. Rynn
  • Annals of Clinical Psychiatry
  • 2005

Efficacy and tolerability of escitalopram in 12 - and 24 - week treatment of social anxiety disorder : randomised , double - blind , placebo controlled , fixed - dose study

  • H. Loft
  • Depression and Anxiety
  • 2004

The epidemiology of generalised anxiety disorder

  • M. Lader, K. Stender, V. Burger
  • Psychiatric Clinics of North America
  • 2001

Similar Papers

Loading similar papers…